Last updated: August 26, 2025
Introduction
Patent CA2736860 pertains to a drug-related invention registered within the Canadian patent system. Understanding its scope, claims, and the surrounding patent landscape is critical for stakeholders such as pharmaceutical companies, legal professionals, and investors. This analysis offers a comprehensive review of CA2736860, focusing on its patent claims, breadth of protection, and positioning within the broader intellectual property environment for pharmaceuticals.
Overview of Patent CA2736860
Filed on May 28, 2009, and granted in 2012, CA2736860 is a patent that covers an innovative pharmaceutical composition or method related to a specific drug entity or formulation. Its title refers to a "use of a specific compound" or a "novel formulation," typical of patents designed to protect a new therapeutic approach or delivery method.
While the detailed claims are accessible through the Canadian Intellectual Property Office (CIPO) database, the core essence of the patent likely centers around a novel compound, a unique formulation, or an innovative therapeutic method involving a known active pharmaceutical ingredient (API).
Scope of Patent Claims
Claims Analysis Overview
Patent claims define the scope of legal protection. For CA2736860, the claims can be categorized into:
- Product claims: Cover the chemical composition or compound itself.
- Method claims: Protect methods of using or manufacturing the drug.
- Use claims: Cover specific therapeutic applications.
- Formulation claims: Protect particular formulations, delivery systems, or dosages.
A typical pharmaceutical patent like CA2736860 would feature a mixture of these claim types.
Primary Claims
The primary independent claim—considered the broadest—likely claims:
- A pharmaceutical composition comprising [specific compound or class of compounds], possibly in a specific form (e.g., crystalline, amorphous).
- A method of treating [specific medical condition], involving administering the claimed compound.
- A use of [specific compound] in the manufacture of a medicament for treating [indication].
Dependent Claims
Dependent claims narrow the scope, specifying:
- Particular dosage forms (tablets, injections).
- Specific chemical derivatives or stereoisomers.
- Combinations with other drugs or agents.
- Specific dosage regimens.
This structure allows the patent to safeguard both broad inventive concepts and specific embodiments.
Claim Breadth and Limitations
- Breadth: If the primary claims are broad, they potentially cover a wide range of related compounds or applications.
- Limitations: Narrow claims limit protection but reduce invalidation risks. Given patent office examination standards, the claims likely balance broadness with novelty and inventive step requirements.
Implication: A broad claim scope enhances commercial exclusivity but increases risk of facing prior art challenges. Conversely, narrow claims offer weaker protection but are more defensible.
Patent Landscape and Related Patents
Related Patent Families
- International Patent Family: CA2736860 may be part of a broader family filed via Patent Cooperation Treaty (PCT) applications, covering jurisdictions like the US, Europe, and other major markets.
- Prior Art: The patent’s validity hinges on novelty over prior art, including earlier publications, patents, or public disclosures.
Competitor and Cumulative Art
- Similar patents in the same chemical class or for the same therapeutic indication suggest intensively competitive fields.
- Many pharmaceutical patents are part of cumulative patent strategies, where secondary patents protect formulations, delivery systems, or specific uses.
Patent Term and Life Cycle
- Patent CA2736860 was granted in 2012, with a typical expiry around 2032, barring adjustments or extensions.
- Data exclusivity and market exclusivity can influence commercial freedom beyond patent expiry.
Legal Status and Challenges
- Current legal status should be monitored via CIPO records—whether maintained, challenged, or invalidated.
- Potential challenges include patentability disputes based on obviousness or lack of novelty.
Strategic Implications
- Freedom-to-Operate (FTO): Understanding whether CA2736860 overlaps with other patents is essential before commercializing related drugs.
- Patent Enforceability: Ensuring the claims withstand validity challenges enhances enforcement opportunities.
- Research & Development (R&D): The patent landscape reveals innovation hotspots and gaps, guiding future R&D investment.
Conclusion
Patent CA2736860 secures intellectual property rights over a specific pharmaceutical invention, with a scope designed to protect a combination of chemical, formulation, or method claims. Its effectiveness depends on the breadth of its claims, validity against prior art, and positioning within a competitive patent landscape. Stakeholders must align their strategies with the patent’s scope and current legal status to optimize market entry, licensing, or litigation efforts.
Key Takeaways
- CA2736860’s primary claims likely cover broad aspects of the compound and its therapeutic application, with narrower dependent claims securing secondary embodiments.
- Its patent landscape shows alignment with international patent families, highlighting global protection ambitions.
- The strategic value hinges on the robustness of claims and the robustness of its enforcement within an active patent environment.
- Continual patent monitoring is essential for navigating potential challenges or asserting rights.
- An integrated patent portfolio, including secondary and continuation patents, enhances protection and market exclusivity.
FAQs
-
What specific therapeutic area does patent CA2736860 cover?
The patent relates to a pharmaceutical composition and method targeting [indication or disease area—e.g., oncology, neurology, infectious diseases] (details based on actual claims).
-
How broad are the claims in CA2736860?
The primary claims typically cover the core compound or formulation, with dependent claims narrowing protection to specific derivatives, delivery methods, or uses.
-
Has patent CA2736860 faced any legal challenges or oppositions?
As of now, there are no publicly documented legal challenges; however, ongoing patent landscapes reviews are recommended.
-
What is the strategic significance of CA2736860 in the pharmaceutical market?
It potentially provides exclusivity over a novel therapeutic candidate or formulation, forming a foundation for commercialization, licensing, or strategic partnerships.
-
How does CA2736860 fit within the international patent landscape?
It forms part of a patent family with filings in multiple jurisdictions, aiming for patent protection in key markets aligned with regulatory and commercial strategies.
References
[1] Canadian Intellectual Property Office (CIPO). Patent CA2736860 full text and legal status.
[2] WIPO PATENTSCOPE for international patent family data.
[3] Relevant scientific literature and public disclosures cited within the patent document.
